Library - Last Five Year Thesis List 2019 - 2024
| Sr. No. | Year | Department | Student Name | Guide Name | Title |
|---|---|---|---|---|---|
| 1. | 2019-2020 | Pharmaceutics | Manjushri Athavale | Dr. A .R. Madgulkar | To Improve Bioavailability Of Sinapic Acid By Oral Route. |
| 2. | 2019-2020 | Pharmaceutics | Dhananjay Pagare | Dr. A .R. Madgulkar | Application Co-Crystals in drug delivery . |
| 3. | 2019-2020 | Pharmaceutics | Tejas Athavale | Dr. A .R. Madgulkar | Formulation & Evaluation of Solid Lipid Nanoparticles to Increase the Oral Bioavailability of A BCS Class II Drugs. |
| 4. | 2019-2020 | Pharmaceutics | Krishna Wadekar | Dr. M. R. Bhalekar | Formulation & Evaluation of Taste Masked Oral Disintegrating Tablets of Citalopram hydrobromide. |
| 5. | 2019-2020 | Pharmaceutics | Mr.Yash Saoji | Dr. A .R. Madgulkar | Evaluation of Approaches in Formulation of Sustained Release Hydrophilic Matrix Tablets. |
| 6. | 2019-2020 | Pharmaceutics | Mr.Ranjitkumar Padakanti | Dr. M. M. Bandivadekar | Formulation & Evaluation of Beta – Cyclodexttrin Based Ritonavir Nanogel for Vaginal Delivery. |
| 7. | 2019-2020 | Pharmaceutics | Mr.Rohit Kharade. | Rahul Paradkar | Development & Evaluation of Wound Healing Dressing Systems. |
| 8. | 2019-2020 | Quality Assurance Techniques | Sayali Sheth | Dr. M. C. Damle. | Development & Validation Of Stability Indicating Method for Active Pharmaceutical Ingredients. |
| 9. | 2019-2020 | Quality Assurance Techniques | Kajal Kabra | Dr. M. C. Damle. | Formulation Evaluation & Stability Studies of Citrus Peel Transdermal Patch & Study of Rivaroxaban Degradation. |
| 10. | 2019-2020 | Quality Assurance Techniques | Pooja Kalaskar | Dr. M. C. Damle. | Method Development & Validation For Estimation of Dugs. |
| 11. | 2019-2020 | Quality Assurance Techniques | Snehal Dalvi | Dr. M. C. Damle. | Method Development for Estimation of Phytoconstituent From Leafe Extract of Nirgundi & Accelerated Stability Study. |
| 12. | 2019-2020 | Quality Assurance Techniques | Mr.Pushpraj Patil | Dr. M. C. Damle. | Method Development & Validation For Estimation of Dugs. |
| 13. | 2019-2020 | Quality Assurance Techniques | Priyanka Pardeshi. | Dr. S. V. Gandhi. | Development & Validation Of Stability Indicating & Chemometric assisted Methods For Drugs. |
| 14. | 2019-2020 | Quality Assurance Techniques | Shubhada Jagdale | Dr. S. V. Gandhi. | Stability – Indicating And Chemometric Assisted Method Development for Estimation of Pharmaceuticals. |
| 15. | 2019-2020 | Quality Assurance Techniques | Jyoti Galande | Dr. S. V. Gandhi. | Stability Indicating & Chemometric Assisted Method Development For Quantification of Drugs. |
| 16. | 2019-2020 | Quality Assurance Techniques | Mohini More. | Dr. S. V. Gandhi. | Stability – Indicating Method Development & Validation for Determination of Pharmaceuticals. |
| 17. | 2019-2020 | Quality Assurance Techniques | Shradha Chaudhari | Dr. S. V. Gandhi. | Estimation of Pharmaceuticals By Stability Indicating & Chemometric assisted Methods. |
| 18. | 2019-2020 | Quality Assurance Techniques | Mr.Sumit Soundale |
DR.P. B. Deshpande
|
Formulation & Evaluation of Herbal Gel Formulation of Murraya Koenigii ( Curry Leaves ) |
| 19. | 2019-2020 | Quality Assurance Techniques | Mr.Aniket Ithape |
DR.P. B. Deshpande
|
Stability – Indicating Analytical Method Development & Validation for Determination of Drugs in Pharmaceutical Formulations. |
| 20. | 2019-2020 | Quality Assurance Techniques | Mr.Israralam Shaikh |
DR.P. B. Deshpande
|
Stability – Indicating Analytical Method Development & Validation for Determination of Drugs in Pharmaceutical Formulations. |
| 21. | 2019-2020 | Quality Assurance Techniques | Mr.Akshay Kale |
DR.P. B. Deshpande
|
Stability – Indicating Analytical Method Development & Validation for Determination of Drugs in Pharmaceutical Formulations. |
| 22. | 2019-2020 | Pharmacology | Mr.Naresh Choudhary | Dr. Ziyaurrahman A.R. | Neuropharmacological Evaluation of Drug Formulation Containing Alangium Salviifolium & Clitoria terntea Extract on |
| 23. | 2019-2020 | Pharmacology | Harshada Lanjekar | Mrs. S. U. Kolhe | Pharmacological Evaluation of Clove oil Emulsion in Hypothyroidism Induce Rat for Enhancing Thyroid Function. |
| 24. | 2019-2020 | Pharmacology | Prajakta Murudkar | Mrs. S. U. Kolhe | Pharmacological Evaluation of Hydro – Alcoholic Extract of Helicters isora Dried fruits for Ulcerative Colities in Experimental Rats. |
| 25. | 2019-2020 | Pharmacology | Shubhangi Deshpande | Mrs. S. U. Kolhe | Evaluation of anti asthmatic activity of Momordica charantia on Experimental animals. |
| 26. | 2019-2020 | Pharmacology | Rutuja Vibhute | Mrs. S. U. Kolhe | Preclinical Evaluation of Hydro alcoholic Extract of SesbaniaSesban Leaves For Antiuler Activity On Rats. |
| 27. | 2019-2020 | Pharmacology | Shivani Salokhe | Mrs. S. U. Kolhe | Pharmacological Evaluation of Rosmarinus officinalis in Neuropathic pain using Experimental Animals. |
| 28. | 2019-2020 | Pharmacology | Deepali Hanamghar | Mrs. S. U. Kolhe | Development & Evaluation of Product Contain Nutrious Supplementary Food for Management of Anemia in Experimental Wistar Rats. |
| 29. | 2019-2020 | Pharmaceutical Chemistry | Rutuja Pawar | Dr. T. S. Chitre | Development Of Anticancer Agents Using Molecular Hybridization Approach. |
| 30. | 2019-2020 | Pharmaceutical Chemistry | Sadeecha Wani | Dr. T. S. Chitre | Design, Synthesis of Some Heterocyclic Derivatives As Antitubercular Agents. |
| 31. | 2019-2020 | Pharmaceutical Chemistry | Muskan Singh | Mrs. K. D. Asgaonkar | Development of Some Anti Tubercular Agents. |
| 32. | 2020 – 2021 | Pharmaceutics | Snehal Hankare | Dr. A .R. Madgulkar | Formulation And Evaluation of Cyclodextrine Based Ritonavir Nanogel. |
| 33. | 2020 – 2021 | Pharmaceutics | Rukhsar Shaikh | Dr. A .R. Madgulkar | Preparation And Evaluation of Co-Processed Excipient Blend for Mouth Dissolve Tablets. |
| 34. | 2020 – 2021 | Pharmaceutics | Mrunal More | Dr. A .R. Madgulkar | Formulation Development And Evaluation of Colon Targeted Drug Delivery For Treatment of Inflammtory Bowel Disease. |
| 35. | 2020 – 2021 | Pharmaceutics | Sakshi Bedmutha | Dr. A .R. Madgulkar | Formulation And Evaluation of solid Lipid Nanoparticles for Oral Drug Delivery of Boswellic Acid for Treatment of Rheumatoid Arthritis. |
| 36. | 2020 – 2021 | Pharmaceutics | Mr.Snehankit Gawade | Dr. A .R. Madgulkar | Evaluation of Pharmaceutical Cocrystals in Formulation. |
| 37. | 2020 – 2021 | Pharmaceutics | Prajakta Mane | Dr. M. R. Bhalekar | Formulation And Evaluation of Rizatriptan Buccal Patch |
| 38. | 2020 – 2021 | Pharmaceutics | Shweta Ahire | Dr. A .R. Madgulkar | Formulation And Evaluation of Topical Sinapic Acid solid Lipid Nanoparticles formulation for Enhanced Anti-Inflammatory Acidity. |
| 39. | 2020 – 2021 | Pharmaceutics | Sharvari Naik | Dr. M. R. Bhalekar | Formulation And Evaluation of sustained Release Matrix Tablet By Using Spray Dried Co-Processed Excipient of Tamarind Seed Polysaccharide And HPMC K4M. |
| 40. | 2020 – 2021 | Pharmaceutics | Mr.Pradip Chavan | Dr. M. R. Bhalekar | Improving Solubility of BCS Class II Drug By Cocrystal Approach. |
| 41. | 2020 – 2021 | Pharmaceutics | Sharwari Sapate | Dr. M .R. P Rao | Formulation and Evaluation of pediatric orodispersible tablet of nevirapine |
| 42. | 2020 – 2021 | Pharmaceutics |
Sayali Sugaonkar
|
Dr. M .R. P Rao | Formulation and Evaluation of Dapsone Loaded Mixed Micellar Gel for Topical Drug Delivery System. |
| 43. | 2020 – 2021 | Pharmaceutics |
Mr.Gajanan Paul
|
Dr. M .R. P Rao | Vaginal Delivery of Clotrimazole by Mucoadhesion for Treatment of Vaginal Candidiasis. |
| 44. | 2020 – 2021 | Pharmaceutics | Mr.Sushant Poul | Dr. M. M. Bandivadekar | Formulation and Evaluation of Beta-Cyclodextrin Based Nevirapine Nanogel. |
| 45. | 2020 – 2021 | Pharmaceutics | Mr.Nikhil Patil | Dr. R. N. Mirajkar | Sustained Release Injection of an Antibiotic Drug Using QBD Appraoch |
| 46. | 2020 – 2021 | Pharmaceutics | Kalyani Shinde | Dr. Rahul Padalkar | Formulation Development And Evaluation of Foam Wound Healing. |
| 47. | 2020 – 2021 | Quality Assurance Techniques | Roshani Pardeshi | Dr. M. C. Damle. | Development & Validation Of Stability Indicating Methods for Bulk Drugs. |
| 48. | 2020 – 2021 | Quality Assurance Techniques | Mrunmayi Pokharkar | Dr. M. C. Damle. | Stability Indicating HPTLC Method Development & Validation For Pazopanib. |
| 49. | 2020 – 2021 | Quality Assurance Techniques | Mayuri Suryawanshi | Dr. M. C. Damle. | Development & Validation Of Stability Indicating Methods for Bulk Drug. |
| 50. | 2020 – 2021 | Quality Assurance Techniques | Mr.Akshay Chandan | Dr. M. C. Damle. | Stability Indicating Method for Rivaroxaban To Monitor Hydrolytic Degradation. |
| 51. | 2020 – 2021 | Quality Assurance Techniques | Mr.Omkar Shinde | Dr. M. C. Damle. | Stability Indicating HPTLC Method Development & Validation For Bedaquiline Fumarate. |
| 52. | 2020-2021 | Quality Assurance Techniques | Mr.Dnyaneshwar Rathod | Dr. M. C. Damle. | Development & Validation Of Stability Indicating Method for Estimation of Drugs. |
| 53. | 2020-2021 | Quality Assurance Techniques | Namrata Bawaskar | Dr. S. V. Gandhi. | Method Development & Validation for Estimation of Pharmaceuticals. |
| 54. | 2020 – 2021 | Quality Assurance Techniques | Smruti Shinde | Dr. S. V. Gandhi. | Development & Validation of Analytical Methods for Pharmaceuticals. |
| 55. | 2020 – 2021 | Quality Assurance Techniques | Mr.Shubham Pawar | Dr. S. V. Gandhi. | Development & Validation of Analytical Methods for Drugs in Combined Dosage Forms. |
| 56. | 2020 – 2021 | Quality Assurance Techniques | Mr.Yogesh Punde | Dr. S. V. Gandhi. | Development & Validation of Analytical Methods for Delamanid. |
| 57. | 2020 – 2021 | Quality Assurance Techniques | Shraddha Jadhav | Dr. M. C. Damle. | Optimization & Evaluation of Pharmacological Activity of Herbal Formulation of Phyllanthus Niruri Extract. |
| 58. | 2020 – 2021 | Quality Assurance Techniques | Mr.Dipak Supe | Dr. P. B. Deshpande | Development & Evaluation of Pharmacological Activity of Gel Containing Murraya Koenigii Extract. |
| 59. | 2020 – 2021 | Quality Assurance Techniques | Shriram Temgire | Dr. P. B. Deshpande | Development & Evaluation of Pharmacological Activity of Pastilles Bacopa Monnieri Extract. |
| 60. | 2020 – 2021 | Quality Assurance Techniques | Mr.Saurabh Jadhav | Dr. P. B. Deshpande | Stability Indicating Analytical Method Development & Validation for Determination of Drugs in Pharmaceutical Formulations. |
| 61. | 2020 – 2021 | Quality Assurance Techniques | Mr.Sandeep Swami | Dr. P. B. Deshpande | Development & Validation Of Stability Indicating Methods for Estimation of Drugs in Pharmaceutical Dosage Form. |
| 62. | 2020 – 2021 | Pharmaceutical Chemistry | Nayana Navsupe | Dr. S. V. Bhandari | Development of Potential Anticancer Agent Using Pharmacophore Optimization of Substituted Pyrimidine Derivatives. |
| 63. | 2020 – 2021 | Pharmaceutical Chemistry | Vrusahli Pathak | Dr. S. V. Bhandari | Design & Development of Potential Anticancer Agent By Molecular Modelling, Molecular Dynamics , Synthetic & Anticancer Activity Studies. |
| 64. | 2020 – 2021 | Pharmaceutical Chemistry | Mr.Vaibhav Raut | Dr. S. V. Bhandari | Development of Potential Anticancer Agent Using Pharmacophore Optimization by Molecular Studies. |
| 65. | 2020 – 2021 | Pharmaceutical Chemistry | Pooja Wagh | Dr. T. S. Chitre | Development of Some Antifungal Agents Containing Triazole & Pyrimidine Scaffold . |
| 66. | 2020 – 2021 | Pharmaceutical Chemistry | Sheetal Parse | Dr. T. S. Chitre | Development of Some Antifungal Agents Containing Thiadiazole & Pyrimidine Scaffold . |
| 67. | 2020 – 2021 | Pharmaceutical Chemistry | Shruti Suryawanshi | Dr. T. S. Chitre | Development of Some Antifungal Agents Containing Oxadiazole& Pyrimidine Scaffold . |
| 68. | 2020 – 2021 | Pharmaceutical Chemistry | Nagaswajanya Dongari | Mrs. K. D. Asgaonkar | Development of Some Antifungal Agents. |
| 69. | 2020 – 2021 | Pharmacology | Shweta Shirurkar | Mrs. S. U. Kolhe | Evalution of Effect of Nutritional Supplementary Herbal Juice in Phenyl Hydrazine Induced Anaemia in Wistar Rats. |
| 70. | 2020 – 2021 | Pharmacology | Gautam Gundecha | Mrs. S. U. Kolhe | Evalution of the Effect of Folic Acid Rich Nutritional Supplement Containing , Hordeum Vulgare, Brassica Oleracea, Zea Mays & Asparagus racemosus in Prevention of Neural Tube Defects. |
| 71. | 2020 – 2021 | Pharmacology | Anup Deshmukh | Mrs. S. U. Kolhe | Evalution of the Effect of Nutritional Supplement Containing Zea Mays, Hordeum Vulgare, Asparagus racemosus, Brassica Oleracea on Vitamins & Micronutrients Status in female rats treated with oral Contraceptives. |
| 72. | 2020 – 2021 | Pharmacology | Anirudha Chaskar | Mrs. S. U. Kolhe | Evalution of Nutritional Supplement Containing Hordeum Vulgare Zea Mays, Asparagus racemosus, Brassica Oleracea on Micronutrients Levels in Experimental Animal Model of Diabetes. |
| 73. | 2020 – 2021 | Pharmacology | Snehal Salve | Dr. Ziyaurrahman A.R. | Evalution of Effect of Cinnamaldehyde in a Prevention of Myocadial Infraction in Albino Wistar Rats. |
| 74. | 2020 – 2021 | Pharmacology | Mr.Kamlesh Patil | Dr. Ziyaurrahman A.R. | To Evaluate the Effect of Nutritional Supplement Containing , Asparagus racemosus , Zea Mays Brassica Oleracea & Hordeum Vulgare for the prevention & management of Malnutrition in Protein restricted Undernourished rat. |
| 75. | 2019-2020 | Pharmaceutics | Nisha Thange | Dr. A .R. Madgulkar |
Evalution of Applications of Chitosan-2-mercaptobenzoic acid ( Thiomer ) |
| 76. | 2019-2020 | Pharmaceutics | Dhanashree Bankar | Dr. M. R. Bhalekar | Development of Coating Formula For Pharmaceutical Applications. |
| 77. | 2021 – 2022 | Pharmaceutics | Bhagyashree Patil | Dr. A .R. Madgulkar | Improving Solubility of BCS Class II Drug By Cocrystal Approach. |
| 78. | 2021 – 2022 | Pharmaceutics | Kiran Honkalas | Dr. A .R. Madgulkar | Application of Cocrystal in Formulation for Dissolution Enhancement of Poorly Soluble Drug. |
| 79. | 2021 – 2022 | Pharmaceutics | Mr.Vaibhav Kapgate | Dr. A .R. Madgulkar | Formulation and Evaluation of Mouth Dissolving Film. |
| 80. | 2021 – 2022 | Pharmaceutics | Aishwarya Katrela | Dr. M. R. Bhalekar | Formulation and Evaluation of Nabumetone Loaded SLN for Its Enhanced Anti-Inflammatory Activity. |
| 81. | 2021 – 2022 | Pharmaceutics | Sanika Meghal | Dr. M. R. Bhalekar | Formulation and Evaluation ofSolid Lipid Nanoparticles for Bioavailability Enhancement of An Anti-Retroviral Drug Efavirenz. |
| 82. | 2021 – 2022 | Quality Assurance Techniques | Pooja Lanke | Dr. M. C. Damle. | Development of Stability Indicating HPTLC Method And Dissolution Test By HPLC . |
| 83. | 2021 – 2022 | Quality Assurance Techniques | Pooja Gurav | Dr. M. C. Damle. | Bio-Analytical Methods for Teriflunomide. |
| 84. | 2021 – 2022 | Quality Assurance Techniques | Meghana Pansare | Dr. M. C. Damle. | Development of Bio-Analytical Methods for Gliclazide And Dissolution Method for Linagliptin. |
| 85. | 2021 – 2022 | Quality Assurance Techniques | Shreya Mantri | Dr. M. C. Damle. | Chromatographic Standardization of cissus Quadrangularis Linn Extract And Stability Testing At Room Temperature. |
| 86. | 2021 – 2022 | Quality Assurance Techniques | Ankita Mahajan | Dr. M. C. Damle. | Stability Indicating HPTLC Method Development for Tavaborole, Trifluridine. |
| 87. | 2021 – 2022 | Quality Assurance Techniques | Mr.Kiran Somshetwar | Dr. M. C. Damle. | Development of Stability Indicating Methods for Molnupiravir. |
| 88. | 2021 – 2022 | Quality Assurance Techniques | Prachi Karwa | Dr. A .R. Madgulkar | Solubility Enhancement of Efavirenz By Pastillation Technique. |
| 89. | 2021 – 2022 | Quality Assurance Techniques | Mr.Jay Mehta | Dr. A .R. Madgulkar | Enhancement of Solubility of Nabumetone By Pastillation Technique. |
| 90. | 2021 – 2022 | Quality Assurance Techniques | Manisha Jagtap | Dr. S. V. Gandhi. | Method Development And Validation for Estimation of Iguratimod In Stability samples And Dissolution Media. |
| 91. | 2021 – 2022 | Quality Assurance Techniques | Shivani Sawarkar | Dr. S. V. Gandhi. | Development And Validation Of Stability Indicating HPLC And HPTLC Methods for Pharmaceuticals. |
| 92. | 2021 – 2022 | Quality Assurance Techniques | Mr.Hanmant Bade | Dr. S. V. Gandhi. | Development And Validation Of Analytical Methods for Estimation of Pharmaceuticals. |
| 93. | 2021 – 2022 | Quality Assurance Techniques | Mr.Vinod Gaikwad | Dr. S. V. Gandhi. | Dissolution Method Development And Validation for Determination of Zidovudine. |
| 94. | 2021 – 2022 | Quality Assurance Techniques | Mr.Vikas Khatik | Dr. S. V. Gandhi. | Method Development And Validation for Estimation of Drugs In Combination. |
| 95. | 2021 – 2022 | Quality Assurance Techniques | Nutan Raut | Dr. P. B. Deshpande | Development & Validation Of Stability Indicating Methods for Determination Pharmaceuticals. |
| 96. | 2021 – 2022 | Quality Assurance Techniques | Snehal Dhamodkar | Dr. P. B. Deshpande | Stability Indicating Analytical Method Development And Validation for Determination of Drugs in Pharmaceutical Formulations. |
| 97. | 2021 – 2022 | Quality Assurance Techniques | Mr.Sushant Deshpande | Dr. P. B. Deshpande | Development And Evaluation of Novel Formulation for Treatment of Acne Vulgaris. |
| 98. | 2020 – 2021 | Pharmacology | Pratima Tambe | Mrs. S. U. Kolhe | Aphrodisiac Activity of Allium Ampeloprasum on Male Rats. |
| 99. | 2020 – 2021 | Pharmacology | Payal Pingle | Mrs. S. U. Kolhe | Pre-Clinical Evaluation of Polyherbal Mixture for Anti-Hyperlipidic And Anti-Obesity Activity on Experimental Rats. |
| 100. | 2020 – 2021 | Pharmacology | Pooja Kolase | Mrs. S. U. Kolhe | Screening of Established NRF2 Activators ( Cinnamaldehyde ) for Their Potential to Attenuate the Progression of Non Alcoholic Fatty Liver Disease ( NAFLD ) In Animal Model of the Disease. |
| 101. | 2021 – 2022 | Pharmacology | Nikita Kedari | Mrs. S. U. Kolhe | Pre-Clinical Evaluation of Hepatoprotective activity of Polyherbal Formulation of Piper Longum, Allium Sativium, Petrocarpus Marsupium on wistar rat. |
| 102. | 2021 – 2022 | Pharmacology | Mr.Aannam Mukhtar Ahmed Bagwan | Mrs. S. U. Kolhe | A Study of Nootropic Activity of Poly Herbal Formulation Containing Brahmi, Ashwagandha And Shatavari in Wistar Rats. |
| 103. | 2021 – 2022 | Pharmaceutical Chemistry | Mr.Om Nagras | Dr. S. V. Bhandari | Design and Development of Potential Anticancer Agents. |
| 104. | 2021 – 2022 | Pharmaceutical Chemistry | Mr.Kaustubh Waghmare | Dr. S. V. Bhandari | Design and Development of Potential Antioxidant Agents Using Molecular Modelling Studies. |
| 105. | 2021 – 2022 | Pharmaceutical Chemistry | Pranjali Kuthe | Dr. S. V. Bhandari | Design and Development of Potential Mono-Carbonyl Curcumin as EGFR Tyrosine Kinase inhibitors using Structure-Based Drug Design . |
| 106. | 2021 – 2022 | Pharmaceutical Chemistry | Shivani Jadhav | Dr. T. S. Chitre | Design and Synthesis of 1,2,4 Triazole Derivatives as Antitubercular Agents Using Molecular Modelling Studies. |
| 107. | 2021 – 2022 | Pharmaceutical Chemistry | Mr.Kalash Shelke | Dr. T. S. Chitre | Design and Synthesis of 1,3,4 Oxadiazole Derivatives as Antifungal Agents. |
| 108. | 2021 – 2022 | Pharmaceutical Chemistry | Mr.Kunal Pradhan | Dr. T. S. Chitre | Design and Development of Potential Heel/Nek2 inhibitors as Anticancer Agents Using Molecular Modelling Studies. |
| 109. | 2021 – 2022 | Pharmaceutical Chemistry | Prajakta Raut | Dr. P. B. Deshpande | Formulation And Development of pH Sensitive Boswellic Acid Colon Targeted Tablets Coated with Eudragit FS 30D. |
| 110. | 2021 – 2022 | Pharmaceutical Chemistry | Sushruti Tanksali | Mrs. K. D. Asgaonkar | Development of Some Anticancer Agents. |
| 111. | 2022 – 2023 | Pharmaceutical Chemistry | Varsha Patil | Mrs. S. M. Patil | Development of Potential Anticancer Agents Using Pharmacophore Optimization by Molecular Modelling Studies. |
| 112. | 2021 – 2022 | Pharmaceutics |
Shraddha Chaskar
|
Dr. M. M. Bandivadekar | Formulation and Evaluation of Gamma-Cyclodextrin based Darunavir Ethanolate Gel for Vaginal Delivery. |
| 113. | 2021 – 2022 | Pharmacology | Apurva Pawar | Mrs. S. U. Kolhe | Evaluation of Poly herbal Formulation Containing Anacyclus Pyrethrum Tinospora Cardifolia and Tribulus Terrestris for its Aphrodisiac Activity in Nicotine Induced Erectile Dysfunction in Male Wistar Rats. |
| 114. | 2021 – 2022 | Quality Assurance Techniques | Varsharani Pawar | Dr. S. V. Gandhi. | Dissolution Method Development And Validation for Estimation of Remogliflozin Etabonate. |
| 115. | 2021 – 2022 | Pharmaceutics | Saloni Sakharwade | Dr. M .R. P Rao | Enhancement of Solubility Of AlbendazoleBy Inclusion Complexation with Nanosponges And Beta Cyclodextrin. |
| 116. | 2021 – 2022 | Pharmaceutics | Ankita Ingale | Dr. M. R. Bhalekar | Application of Pastillation technology to improve Bioavailability of Darunavir. |
| 117. | 2021 – 2022 | Pharmaceutics | Mr.Shyamsundar Dhage | Dr. M. R. Bhalekar | Sustained – release in situ gel formulation of the Clotrimazole drug for ophthalmic treatment. |
| 118. | 2021 – 2022 | Pharmaceutics | Jidnyasa Pawar | Dr. M .R. P Rao | Solubility Enhancement of Nevirapine Using Beta – CclodextrinNanosponges. |
| 119. | 2021 – 2022 | Pharmaceutics | Mr.Abhishek Harne | Dr. M .R. P Rao | Formulation and Development of Topical Forming Gel of Fluconazole. |
| 120. | 2022 – 2023 | Pharmaceutical Chemistry | Mrunal Belwate | Dr. S. V. Bhandari | Design and Development of Anticancer Agents Using Molecular Modeling Studies. |
| 121. | 2022 – 2023 | Pharmaceutical Chemistry | Mr.Sagar Birajdar | Dr. S. V. Bhandari | Design and Development of Anticancer Agents Using Pharmacophore optimization by molecular Modeling Studies. |
| 122. | 2022 – 2023 | Pharmaceutical Chemistry | Mr.Shivraj Mawale | Dr. S. V. Bhandari | Design and Development of Anticancer Agents Using Structure based Drug Design. |
| 123. | 2022 – 2023 | Pharmaceutical Chemistry | Mr.Sandip Surve | Dr. S. V. Bhandari | Design and Development of Potential anticancer Agents Using molecular Modeling Studies. |
| 124. | 2022 – 2023 | Pharmaceutical Chemistry | Mr.Purvaj Hirode | Dr. T. S. Chitre | Synthesis and In – silico studies of Anticancer Agents. |
| 125. | 2022 – 2023 | Pharmaceutical Chemistry | Mr.Aniket Bhatambrekar | Dr. T. S. Chitre | Design , Synthesis and Biological Evaluation of Anti – inflammatory Agents. |
| 126. | 2022 – 2023 | Pharmaceutical Chemistry | Shubhangi Thorat | Dr. T. S. Chitre | Design and Development of Potential Anti – inflammatory Agents Using molecular Modeling Studies. |
| 127. | 2022 – 2023 | Pharmaceutical Chemistry | Sayali Hajare | Dr. T. S. Chitre | Development of Potential Anti – Cancer Agents Using molecular Modeling Studies. |
| 128. | 2022 – 2023 | Pharmaceutical Chemistry | Ashwini Sagar | Mrs. K. D. Asgaonkar | Design and Synthesis and antifungal Agents of some Hetrocyclic Compound. |
| 129. | 2022 – 2023 | Pharmaceutical Chemistry | Krishna Shevate | Mrs. K. D. Asgaonkar | Development of some antifungal Agents. |
| 130. | 2022 – 2023 | Pharmaceutical Chemistry | Vrushali Randive | Mrs. S. M. Patil | Pharmacophore optimization of some Hytrocycles for Treatment of Cancer. |
| 131. | 2022 – 2023 | Pharmaceutical Chemistry | Indrani Mahadik | Mrs. S. M. Patil | Design , Synthesis and Biological Evaluation of Thiadiazole Derivatives as Anti – Cancer Agents. |
| 132. | 2022 – 2023 | Pharmacology | Anjali Mundhe | Mrs. S. U. Kolhe | Evaluation of the Anxiolytic effect of Glyeyrrhiza Glabra in Material separation and cold stress induced Model in young rats. |
| 133. | 2022 – 2023 | Pharmacology | Asawari Mansabdar | Mrs. S. U. Kolhe | Evaluation of Neuroprotective Activity of Macrotyloma uniflorum seed Extract in Experimental Model of rats. |
| 134. | 2022 – 2023 | Pharmacology | Reshma Shelar | Mrs. S. U. Kolhe | Investigation of the effect of marketed probiotic Formulations in Non-Alcoholic Fatty Liver Disease in wistar rats. |
| 135. | 2022 – 2023 | Pharmacology | Chetashri Patil | Mrs. S. U. Kolhe | Investigation of Possible Beneficial role of Cinnamomum zeylanieum in Autism Spectrum Disorder Related Phenotypes in Albino Wistar Rat. |
| 136. | 2022 – 2023 | Pharmacology | Mr.Swapnil Lad | Mrs. S. U. Kolhe | Evaluation of Antihyperlipidemic potential of Colocasia Esculenta Corms in Experimental Model of Rats. |
| 137. | 2022 – 2023 | Pharmacology | Mr.Sushrut Oza | Mrs. S. U. Kolhe | Investigation of the hepatoprotective Potential of Ricinus Communis Leaf Induced Hepatotoxicity Models in Rats. |
| 138. | 2022 – 2023 | Pharmacology | Mr.Manthan Rode | Mrs. S. U. Kolhe | Evaluation of Beneficial Effects of Glycyrrhiza Glabra Roat Extract in Autism Spectrum Disorder Related Phenotypes in Albino Wistar Rats. |
| 139. | 2022 – 2023 | Pharmacology | Mr.Rohit Nalawade | Mrs. S. U. Kolhe | To evaluate the Antihyperlipidemic Activity of Adenocalymma Alliaceum in Experimental Model of Rats. |
| 140. | 2022 – 2023 | Pharmacology | Mr.Aniket Vasatkar | Dr. Ziyaurrahman A.R. | Effect of Millet Based Nutritional Composition on Neurobehavioral Parameters in Prenatal and postnatal stage in undernourished Rats. |
| 141. | 2022 – 2023 | Pharmacology | Mr.Saurabh Ade | Dr. Ziyaurrahman A.R. | Evaluation of Anti-Obesity Potential of Luffa Acutangula in Cafeteria Diet Induced young obese Rats. |
| 142. | 2022 – 2023 | Pharmacology | Priyanka Waghulde | Dr. Ziyaurrahman A.R. | Investigation of Ameliorative effect of Methanolic Extract of Tectona Grandis Flower on Drug Induced Nephrotoxicity in wistar rats. |
| 143. | 2022 – 2023 | Pharmacology | Mansi Jagdale | Dr. Ziyaurrahman A.R. | Study of Nutritional composition containing Millets for its Health Promating effects in Protein Deficient undernourished Rats. |
| 144. | 2022 – 2023 | Pharmacology | Mansi Kulkarni | Dr. Ziyaurrahman A.R. | Evaluation of wound Healing Activity of Topical Formulations of Dapsone loaded silver Nanoparticles in Experimental Model of wistar rats. |
| 145. | 2022 – 2023 | Pharmacology | Mitali Dange | Dr. Ziyaurrahman A.R. | Wound Healing Activity of Topical formulations containing Bovine colostrums in Experimental Model of rats. |
| 146. | 2022 – 2023 | Quality Assurance Techniques | Mr.Abhijeet Bidkar | Dr. S. V. Gandhi. | Development & Validation Of Methods for Estimation of Pharmaceuticals. |
| 147. | 2022 – 2023 | Quality Assurance Techniques | Mr.Sudarshan Galgunde | Dr. S. V. Gandhi. | Development & Validation Of Stability Indicating Methods for Estimation of Prucalopride succinale. |
| 148. | 2022 – 2023 | Quality Assurance Techniques | Mr.Amol Sonawane | Dr. S. V. Gandhi. | Development & Validation Of Stability Indicating HPLC and HPTLC Method for Active Pharmaceutical Ingredient. |
| 149. | 2022 – 2023 | Quality Assurance Techniques | Vrushali Varpe | Dr. S. V. Gandhi. | Development & Evaluation of Herbal Formulation for Anti-Acne Activity. |
| 150. | 2022 – 2023 | Quality Assurance Techniques | Urja Moon | Dr. S. V. Gandhi. | Formulation and Evaluation of self Micro Emulsifying Drug Delivery System (SMEDDS) Loade with Pongamia Pinnata Extract. |
| 151. | 2022 – 2023 | Quality Assurance Techniques | Prajakta Chauthe | Dr. S. V. Gandhi. | Stability Indicating Method Development by HPLC and HPTLC Techniques. |
| 152. | 2022 – 2023 | Quality Assurance Techniques | Payal Kaitkar | Dr. M. C. Damle. | Development Of Bioanalytical method for Brivaracetam and Stability Indicating Method for Everolimus . |
| 153. | 2022 – 2023 | Quality Assurance Techniques | Pratima Meshram | Dr. M. C. Damle. | Chromatographic Method development and validation for Estimation of Drugs. |
| 154. | 2022 – 2023 | Quality Assurance Techniques | Shubhangi Bidkar | Dr. M. C. Damle. | Development & Validation Of Stability Indicating Methods . |
| 155. | 2022 – 2023 | Quality Assurance Techniques | Mr.Ritesh Khairnar | Dr. M. C. Damle. | Chromatographic Method development and validation for Estimation of Drugs. |
| 156. | 2022 – 2023 | Quality Assurance Techniques | Mr.Akash Bhusari | Dr. M. C. Damle. | Development & Validation Of Stability Indicating Methods . |
| 157. | 2022 – 2023 | Quality Assurance Techniques | Mr.Jay Sonule | Dr. M. C. Damle. | Development & Validation Of Stability Indicating Methods . |
| 158. | 2022 – 2023 | Quality Assurance Techniques | Arti Khadtare | Dr. P. B. Deshpande | Development & Validation Of Stability Indicating Methods . |
| 159. | 2022 – 2023 | Pharmaceutics | Shruti Dhande | Dr. A .R. Madgulkar | Formulation and Evaluation of sustained Release Anti-fungal in Situnasal Gel Loaded with Fluconazole Liposomes. |
| 160. | 2022 – 2023 | Pharmaceutics | Reshma Mate | Dr. A .R. Madgulkar | Development & Evaluation of Diabetic wound Healing Formulation. |
| 161. | 2022 – 2023 | Pharmaceutics | Shraddha Phalake | Dr. A .R. Madgulkar | Formulation and Evaluation of Pastilles and solid Disperation of cinnamon Extract for Enhancing its Anti-Diabetic Activity. |
| 162. | 2022 – 2023 | Pharmaceutics | Mr.Suraj Gurav | Dr. A .R. Madgulkar | Development of SLN Based Dry powder Inhales and solid Dispersion . |
| 163. | 2022 – 2023 | Pharmaceutics | Vrashali Patil | Dr. M. R. Bhalekar | Bioavailability Enhancement of Carvedilol Through Cocrystal Formation. |
| 164. | 2022 – 2023 | Pharmaceutics | Divya Wagh | Dr. M. R. Bhalekar | Dissolution Enhancement of BCS-Class II Drugs using Cocrystal Approach. |
| 165. | 2022 – 2023 | Pharmaceutics | Aditi Pande | Dr. M. R. Bhalekar | Formulation and Characterization of solid lipid Nanoparticles and solid Dispersion to Enhance the Bioavailability of Rilpivirine. |
| 166. | 2022 – 2023 | Pharmaceutics | Mayuri Ghavte | Dr. M. R. Bhalekar | Formulation and Evaluation of Eudragit Fs30D Coated Microspheres of Boswellie Acid and Cinnamon Extract for colon Targeting. |
| 167. | 2022 – 2023 | Pharmaceutics | Poonam Misal | Dr. M .R. P Rao | Formulation and Evaluation of Novel sun Peotective Emulgel containing Phytoconstituents. |
| 168. | 2022 – 2023 | Pharmaceutics | Pranjali Gaikwad | Dr. M .R. P Rao | Formulation and Evaluation of Polymeric Micelle based Sunscreen Gel Containing Phytoconstituents. |
| 169. | 2022 – 2023 | Pharmaceutics | Mr.Ayush Sadanshive | Dr. M. M. Bandivadekar | Formulation and Evaluation of Beta – cyaod extrim based micanazole Nitrate Nanogel for vaginal Delivery. |
| 170. | 2022 – 2023 | Pharmaceutics | Aishwarya Sambare | Dr. M. M. Bandivadekar | Formulation and Evaluation of Beta – cyaod extrin based miconazole Nitrate Nanogel forvaginal delivery. |
| 171. | 2022 – 2023 | Pharmaceutics | Mr.Abhishek Pawar | Dr. Rahul Padalkar | Formulation Development and Evaluation of Hemostatic dressing system. |
| 172. | 2022 – 2023 | Pharmaceutics | Mr.Darshan Karmankar | Dr. Reshma Mirajkar | Formulation and Evaluation of sustained release insitu gel forming intra-articular injection loaded with etoricoxib liposomes. |
| 173. | 2022 – 2023 | Pharmaceutics | Vaibhav Narale | Dr. M .R. P Rao | Solubility enhancement of Efonidpine Using B-Cyclodextrin based Nanosponges. |
| 174. | 2021 – 2022 | Pharmaceutics | Aditi Jadhav | Dr. M. M. Bandivadekar | Formulation and Evaluation of Gamma – Cyclodextrin Based Clotrimazole Nanogel. |
| 175. | 2022 – 2023 | Pharmaceutics | Dhanashri Wable | Dr. M .R. P Rao | Formulation and Evaluation of mucoadhesive buccal tablets of Budesonide using B-cyclodextrin Nanosponges. |
| 176. | 2019 – 2020 | Pharmaceutics | Mr.Abhimanyu Utturkar | Dr. M .R. P Rao | Formulation and Evaluation of Colon targeted matrix tablets of Budesonide, to treat Ulcerative colitis. |
| 177. | 2023 – 2024 | Pharmaceutical Chemistry | Shambhavi Singh | Dr . S. V. Bhandari | Design and Development of Potential Antineoplastic Agents by Pharmacophore Optimization Using Molecular Modeling Studies. |
| 178. | 2023 – 2024 | Pharmaceutical Chemistry | Neha Raut | Dr . S. V. Bhandari | Design and Development of Potential Anticancer Heterocycles Using Molecular Modeling Tools. |
| 179. | 2023 – 2024 | Pharmaceutical Chemistry | Sharayu Ninave | Dr . S. V. Bhandari | Design and Development of Potential Heterocyclic Anticancer Agents. |
| 180. | 2023 – 2024 | Pharmaceutical Chemistry | Mr.Abhishek Shitole | Dr . S. V. Bhandari | Design and Development of Potential Anticancer Agents Using Molecular Modeling Studies. |
| 181. | 2023 – 2024 | Pharmaceutical Chemistry | Mr.Sagar Ghanwat | Dr . S. V. Bhandari | Design and Development of Potential Antineoplastic Agents Using Molecular Modeling Studies. |
| 182. | 2023 – 2024 | Pharmaceutical Chemistry | Sakshi Jagdale | Dr. T. S. Chitre | Design and Development of some Heterocycles for Anticancer Activity. |
| 183. | 2023 – 2024 | Pharmaceutical Chemistry | Snehal Sonwane | Dr. T. S. Chitre | Design and Development of some Heterocycles for Anticancer Activity. |
| 184. | 2023 – 2024 | Pharmaceutical Chemistry | Neha Mhetre | Dr. T. S. Chitre | Design Synthesis and Anticancer Activity.of some Pyrazole Derivatives. |
| 185. | 2023 – 2024 | Pharmaceutical Chemistry | Mr.Aditya Sawant | Dr. T. S. Chitre | Design and Development of some Anticancer Agents. |
| 186. | 2023 – 2024 | Pharmaceutical Chemistry | Dipti Ghate | Mrs. K. D. Asgaonkar | Design and Development of some Antibacterial Agents. |
| 187. | 2023 – 2024 | Pharmaceutical Chemistry | Akshata Naik | Mrs. K. D. Asgaonkar | Development of some Pyrazole Based Antibacterial Agents. |
| 188. | 2023 – 2024 | Pharmaceutical Chemistry | Mr.Parth Shah | Mrs. K. D. Asgaonkar | Design and Development of some Antifungal Agents. |
| 189. | 2023 – 2024 | Pharmaceutical Chemistry | Aishwarya Edake | Mrs. S. M. Patil | Design and Development of some Pyrazole Derivatives. |
| 190. | 2023 – 2024 | Pharmaceutical Chemistry | Mr.Piyush Nikalje | Mrs. S. M. Patil | Design and Development of some Heterocycles for Anticancer Activity. |
| 191. | 2023 – 2024 | Quality Assurance Techniques | Pragati Jadhao | Dr. M. C. Damle | Formulation of Medicated Chewing Gum Containing Salvadora Persica and Punica Granatum Using DoE and Its Evaluation. |
| 192. | 2023 – 2024 | Quality Assurance Techniques | Pallavi Kapratvar | Dr. M. C. Damle | Stability Indicating Methods for Butamirate Citrate Solubility Enhancement of Nabumetone by Co- Amorphous Formulation. |
| 193. | 2023 – 2024 | Quality Assurance Techniques | Akanksha Sujgure | Dr. M. C. Damle | Development and Validation of Analytical Methods. |
| 194. | 2023 – 2024 | Quality Assurance Techniques | Mr.Shankar Maind | Dr. M. C. Damle | Stability Indicating HPLC Method for Empagliflozin and Development of HPTLC Method for Simultaneous Estimation of Empagliflozin, Metformin, Linagliptin. |
| 195. | 2023 – 2024 | Quality Assurance Techniques | Mr.Raj Dhodi | Dr. M. C. Damle | Stability Indicating chromatographic Methods for Flecainide Acetate and Development and Validation of Dissolution Method for Flecainide Acetate Tablets. |
| 196. | 2023 – 2024 | Quality Assurance Techniques | Mr.Abhishek Dabade | Dr. M. C. Damle | Development of Stability Indicating Methods and Bio-Analytical Method for Alutamide. |
| 197. | 2023 – 2024 | Quality Assurance Techniques | Pallavi Pohane | Dr. S. V. Gandhi. | Method Development and Validation for Estimation of Drug in Bulk and Formulation. |
| 198. | 2023 – 2024 | Quality Assurance Techniques | Samriddhi Pachpor | Dr. S. V. Gandhi. | Formulation and Evaluation of Herbal Nanoemulgels. |
| 199. | 2023 – 2024 | Quality Assurance Techniques | Vaishnavi Warwatte | Dr. S. V. Gandhi. | Formulation of Mouth Dissolving Film and Analytical Method Development. |
| 200. | 2023 – 2024 | Quality Assurance Techniques | Mr.Sanket Nanekar | Dr. S. V. Gandhi. | Analytical Method Development and Validation for Estimation of Drugs in Multicomponent Formulation. |
| 201. | 2023 – 2024 | Quality Assurance Techniques | Mr.Abhiraj Auti | Dr. S. V. Gandhi. | Formulation and Characterization of Cubosomes. |
| 202. | 2023 – 2024 | Quality Assurance Techniques | Mr.Syed Shahid Nauman Raees Hashmi | Dr. S. V. Gandhi. | Method Development and Validation for Determination of Active Pharmaceutical Ingredients. |
| 203. | 2023 – 2024 | Quality Assurance Techniques | Sayali Kohakade | Dr. P. B. Deshpande | Development and Validation of Stability Indicating Methods for Estimation of Drugs. |
| 204. | 2023 – 2024 | Quality Assurance Techniques | Rutuja Parit | Dr. P. B. Deshpande | Central Composite Design Based Optimization Studies of Physio-Mechanistic Properties of Bauhinia racemosa Films for Wound Healing. |
| 205. | 2023 – 2024 | Quality Assurance Techniques | Pratiksha Shinde | Dr. P. B. Deshpande | Design and Evaluation of Topical Patches Containing Bioactive Fraction from the Flowers of Calendula Officinalis. |
| 206. | 2023 – 2024 | Quality Assurance Techniques | Pooja Badgujar | Dr. P. B. Deshpande | Formulation and Evaluation of Musa-paradisica for antibacterial activity. |
| 207. | 2023 – 2024 | Quality Assurance Techniques | Sakshi Bhendekar | Dr. P. B. Deshpande | Formulation and Evaluation of Quercetin Loaded Nanoemulgel for Diabetic Wound Healing. |
| 208. | 2023 – 2024 | Quality Assurance Techniques | Shivani Kolekar | Dr. P. B. Deshpande | Formulation and Evaluation of Gastro-Retentive Suspension of Teneligliptin Using In-Situ Gel Method. |
| 209. | 2023 – 2024 | Quality Assurance Techniques | Abhishek Pawane | Dr. P. B. Deshpande | Validated Stability Indicating Method Development and validation for Simultaneous Estimation of Drugs as Bulk and in Pharmaceutical Formulations. |
| 210. | 2023 – 2024 | Pharmacology | Vrushali Dongare | Dr. S. U. Kolhe | Pharmacological Screening of Hydroalcoholic |
| 211. | 2023 – 2024 | Pharmacology | Jyoti Todkar | Dr. S. U. Kolhe | To Evaluate the Neuroprotective Activity of Flower Extract of Couroupita Guianensis in a Haloperidol and Chlorpromazine Induced Parkinsonism in Rats. |
| 212. | 2023 – 2024 | Pharmacology | Simran Bhuraguda | Dr. S. U. Kolhe | Expoloring the Therapeutic Potential of Tinospora cordifolia root exract in ameliorating Austism spectrum Disorder related phenotypes in Albino Wistar Rats. |
| 213. | 2023 – 2024 | Pharmacology | Sakshi Khairatkar | Dr. S. U. Kolhe | Assessing the Therapeutic Potential of Hydroalcoholic Extract of Rhodiola rosea root in Modulating Neurobehavioral symptoms of Austim Spectrum Disorder in albino Wistar rats. |
| 214. | 2023 – 2024 | Pharmacology | Mr.Shubham Gaikwad | Dr. S. U. Kolhe | Evaluation of Hepatoprotective effect of hydroalcoholic extract of Acalypha Indica on Isoniazid / Valproic acid-induced Hepatotoxicity in Wistar rats. |
| 215. | 2023 – 2024 | Pharmacology | Mr.Durgesh Patil | Dr. S. U. Kolhe | To evaluate the beneficial effects of polyherbal extract on ulcerative colitis in wistar rats. |
| 216. | 2023 – 2024 | Pharmacology | Mr.Onkar Mandlik | Dr. S. U. Kolhe | Evaluation of leaf extract of Alliumfistulosum for antihypertensive activity in L-NAME and dexamethasone induced hypertension model in wistar rats. |
| 217. | 2023 – 2024 | Pharmacology | Tapasya Shaha | Dr. Aniket Garud | Evaluation of Wound Healing Activity of Hydrogel Film made up to Tea waste Cellulose loaded with Dapsone-Silver Nanoparticles conjugate in Experimental Model of Wister Rats. |
| 218. | 2023 – 2024 | Pharmacology | Nikita Parchake | Dr. Aniket Garud | To Evaluate the Activity of Beta-Sitosterol as an Estrogenic Agent Using Ovariectomized Rat Model. |
| 219. | 2023 – 2024 | Pharmacology | Mr.Nakul Bornare | Dr. Aniket Garud | Pharmacological Screening of Dhoop and Spray Containing oil of Pela rgonium graveolens and Nyctanthes arbor tristis for its Anticonvulsant activity . |
| 220. | 2023 – 2024 | Pharmacology | Mr.Atharva Deo | Dr. Aniket Garud | Evaluation of Selenium Nanoparticles Conjugated with Curcumin forinhibition of Amyloid aggregation in Aluminium chloride induced Neurobehavioral deficit rat model. |
| 221. | 2023 – 2024 | Pharmacology | Swarupa Sul | Dr. Swati Jogdand | Assessing the Effect of soyprotein on pharmacokinetic profile of efavirenz in albino Wistar rats. |
| 222. | 2023 – 2024 | Pharmacology | Prajakta Salunke | Dr. Swati Jogdand | Evaluation of immunomdulatory activity of ethanolic extract of fruits of Withania coagulans on cyclophosphamide induced immunosuppression in wistar rat. |
| 223. | 2023 – 2024 | Pharmacology | Mr.Vickey Aimganti | Dr. Swati Jogdand | Evaluation of protective effect of Gallic acid in Cuprizone Induced Multiple sclerosis in Wistar Rats. |
| 224. | 2023 – 2024 | Pharmaceutics | Sonali Musmude | Dr. A .R. Madgulkar | Formulation and Evaluation of Sinapic Acid Loaded SLN Hydrogel for Burn Wound Healing. |
| 225. | 2023 – 2024 | Pharmaceutics | Rutuja Sultanpure | Dr. A .R. Madgulkar | Formulation and Evaluation of Hydrogel for Diabetic Wound Healing. |
| 226. | 2023 – 2024 | Pharmaceutics | Mr.Ashish Chavanke | Dr. A .R. Madgulkar | Formulation and Evaluation of Immediate Release Mouth Dissolving Film of Anti-Migraine Drug. |
| 227. | 2023 – 2024 | Pharmaceutics | Mr.Abhishek Kunjir | Dr. A .R. Madgulkar | Solubility Enhancement of BCS Class II drug by Co-amorphous formulation. |
| 228. | 2023 – 2024 | Pharmaceutics | Tanvi Raut | Dr. M. R. Bhalekar | Formulation and Evaluation of Cocrystal for Skin and GI Permeation Enhancement. |
| 229. | 2023 – 2024 | Pharmaceutics | Mr.Hanuman Sutar | Dr. M. R. Bhalekar | Formulation and Evaluation of Beta sitosterol SLN loaded Transdermal patch for Rheumatoid Arthritis. |
| 230. | 2023 – 2024 | Pharmaceutics | Mr.Kunal Thaware | Dr. M. R. Bhalekar | Applications of Cocrystals in Drug Delivery System. |
| 231. | 2023 – 2024 | Pharmaceutics | Mr.Vikrant Meghale | Dr. M. R. Bhalekar | Nanoformulation of solid lipids Nanoparticles of Costus Igneus Extract for Enhanced Antidiabetic Activity. |
| 232. | 2023 – 2024 | Pharmaceutics | Nivedita Borawadekar | Dr. M. M. Bandivadekar | Solubility and Dissolution enhancement study of Cefditoren Pivoxil using solid dispersion Technique. |
| 233. | 2023 – 2024 | Pharmaceutics | Mr.Raviraj Bhise | Dr. M. M. Bandivadekar | Solubility and Dissolution enhancement study of Lopinavir using solid dispersion Technique. |
| 234. | 2023 – 2024 | Pharmaceutics | Nikhil Marathe | Dr. R. Padalkar. | Formulation and Evaluation of foam based hemostasisdressing system. |
| 235. | 2023 – 2024 | Pharmaceutics | Shatakshi Gaikwad | Dr. M .R. P Rao | Formulation and Evaluation of Topical Liposomal Gel. |
| 236. | 2023 – 2024 | Pharmaceutics | Mr.Prafull Suryawanshi | Dr. M .R. P Rao | Solubility Enhancement of Clinidipine Using B – Cyclodextrin Based Nanosponges. |
| 237. | 2023 – 2024 | Pharmaceutics | Mr.Ashok Achane | Dr. M .R. P Rao | Development and Evaluation of SMEDDS tablet using Efonidipine. |
| 238. | 2023 – 2024 | Pharmaceutics | Mr.Ashutosh Talathi | Dr. M .R. P Rao | Formulation and Evaluation of Topical Liposomal Gel of Clotrimazole and Quercetin. |
| 239. | 2023 – 2024 | Pharmaceutics | Mr.Bandenawaz Shaikh | Jitendra Gajbe. | Formulation and Evaluation of Anti-inflammatory Etoricoxib Bigel for Topical Application. |
| 240. | 2023 – 2024 | Pharmacology | Shital Moghe | Dr. Aniket Garud | Effect of Soyprotein on Pharmacokinetic profile of Itraconazole in malnourished rats. |
| 241. | 2023 – 2024 | Pharmacology | Nikita Gundile | Dr. Swati Kolhe | Evaluation of Fruit extract of Coccinia grandis for anti-obesity activity in Wistar rats on a cafeteria diet. |
| 242. | 2023 – 2024 | Pharmacology | Shrushti Jadhav | Dr. Swati Jogdand | Pharmacological Evaluation of Selenium nanoparticles encapsulated with curcumin of Inflammatory bowel disease on Male wistar rats. |
| 243. | 2012 – 2013 | Pharmacology | Ranjeet Markad | Dr. Ziyaurrahman A. R. | Preclinical Screening of aldehyde Derivative for AntihyperlipidemicActivity in Laboratory Animals. |